TYBR Health's Innovative B3 GEL™ System Transforms Recovery
Flowable Gel System Used in First U.S. Orthopedic Soft-Tissue Cases to Support Post-Surgical Healing
TYBR Health, a leader in regenerative medicine focused on enhancing post-surgical healing, has recently announced the first clinical application of its groundbreaking B3 GEL™ System in the United States. This milestone was achieved by Dr. Hanna Tammam, a skilled hand, elbow, and shoulder surgeon, who implemented the system during orthopedic procedures, marking a significant advancement in utilizing biomaterials for patient care.
How the B3 GEL™ System Works
The B3 GEL™ System utilizes a specially formulated collagen-based gel derived from extracellular matrix (ECM). Unlike traditional barriers that are challenging to position in compact areas of the body, this unique gel is flowable, allowing it to fit snugly against tissue. It plays a vital role in maintaining biomechanical separation during the crucial healing period, gradually being resorbed by the body as healing progresses. Recent studies highlight that ECM-based hydrogels can positively influence the early stages of healing, enabling the body to effectively initiate its natural repair processes.
Clinical Applications and Success Stories
Dr. Tammam shared insights from her firsthand experience: "In a complex flexor tendon reconstruction, I placed the B3 GEL™ directly over the surgical site. The gel quickly set, provided excellent visibility, and facilitated smooth tendon movement without hindrance. I later applied it to two additional tendon repair cases, and the outcomes were consistently positive—improved motion range, minimal stiffness, and no complications—outcomes that are very promising for our patients.”
Significance of the B3 GEL™ System in Surgery
Chris Wright, the Chief Commercial Officer of TYBR Health, remarked, "The initiation of B3 GEL™ System usage in the U.S. marks a critical transition for TYBR Health, moving from regulatory oversight to tangible clinical utility. These procedures enable surgeons to effectively combat post-surgical tissue tethering, a common issue that can prolong recovery and limit mobility. By ensuring proper healing of tissues during this vital period, the B3 GEL™ can significantly enhance patient outcomes and expedite the recovery process. We are eager to follow up on the promising results that align with our commitment to improve lives for those undergoing tendon, ligament, and muscle surgeries.”
Future Plans for B3 GEL™ System
TYBR Health is committed to collaborating with medical professionals to broaden the clinical application of the B3 GEL™ System and will further carry out post-market surveillance studies. This will allow the company to gather real-world data on the performance of the B3 GEL™ System and understand its impacts on patient recovery across various surgical environments.
About TYBR Health
TYBR Health is dedicated to developing innovative solutions aimed at safeguarding healing tissues post-surgery, striving to enhance functional restoration and improve the recovery experience for patients. The B3 GEL™ System, their flagship product, has obtained FDA clearance to assist in the protection of soft tissues during recovery. For more details, visit www.tybrhealth.com.
Frequently Asked Questions
What is the B3 GEL™ System?
The B3 GEL™ System is a collagen-based tissue protective gel that enhances post-surgical recovery by conforming to and protecting soft tissues during healing.
Who developed the B3 GEL™ System?
TYBR Health, a regenerative medicine and medical device company, developed the B3 GEL™ System to improve post-surgical outcomes.
How is the B3 GEL™ System applied?
The gel is applied directly to the surgical site during procedures, providing critical support to healing tissues while allowing for natural recovery.
What are the benefits of using the B3 GEL™ System?
The gel promotes better healing by maintaining tissue separation, which helps reduce complications and improve recovery times after surgery.
Is the B3 GEL™ System FDA approved?
Yes, the B3 GEL™ System has received FDA clearance to assist in the protection of soft tissues during the post-surgical healing process.
